Category:
Prophylactic Biological Products
CAS NO:
1072833-77-2
Standard:
USP,
Sintaho Pharmaceutical Ltd was established in the year of 2016 and headquartered in Chongqing China, with a grand vison of being the most trusted partner to pharmaceutical companies worldwide. We have a clear focus on developing and manufacturing highly potent and cytotoxic Active Pharmaceutical Ingredients (APIs) and CDMO services.
Ixazomib Citrate is a pharmaceutical intermediate used in the synthesis of oral proteasome inhibitors. The core process involves coupling ixazomib with citric acid to enhance stability. Molecular Formula: C27H35N6O8P; CAS No.: 1249069-76-8.
Store below 25°C in dry, inert atmosphere. Handle with PPE due to potential cytotoxicity. Strictly adhere to GMP guidelines for clinical distribution.